Smith Asset Management Group LP

SEC CIK: 0001091561
Latest filing: Aug 6, 2021

SEC filings (opens in a new tab)

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Smith Asset Management Group LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overview All 13F holders of ARWR Full Q2 2021 holdings

Shares (Q2 2021): 110
Value: $9.00K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2021

Holdings of ARWR by Smith Asset Management Group LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2021	110	$9.00K	<0.1%	00.0%	Unchanged	Holders
Q1 2021	110	$7.00K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.